DiaMedica Therapeutics
DMAC
DMAC
28 hedge funds and large institutions have $7.42M invested in DiaMedica Therapeutics in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 7 closing their positions.
Holders
28
Holders Change
-6
Holders Change %
-17.65%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
7
Reduced
6
Closed
7
Calls
$175K
Puts
$57K
Net Calls
+$118K
Net Calls Change
+$48K
Top Buyers
1 |
CF
1
Cantor Fitzgerald
New York
|
$30K |
2 |
2
Morgan Stanley
New York
|
$96K |
3 |
3
BlackRock
New York
|
$135K |
4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$357K |
5 |
5
UBS Group
Zurich,
Switzerland
|
$6K |